UGT1A9 anticorps (N-Term)
Aperçu rapide pour UGT1A9 anticorps (N-Term) (ABIN636089)
Antigène
Voir toutes UGT1A9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- UGT1 A9 antibody was raised against the N terminal of µgT1 9
-
Purification
- Affinity purified
-
Immunogène
- UGT1 A9 antibody was raised using the N terminal of µgT1 9 corresponding to a region with amino acids LLMGSYNDIFDLFFSNCRSLFKDKKLVEYLKESSFDAVFLDPFDNCGLIV
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
UGT1A9 Blocking Peptide, (ABIN5616901), is also available for use as a blocking control in assays to test for specificity of this µgT1A9 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of µgT0 9 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- UGT1A9 (UDP Glucuronosyltransferase 1 Family, Polypeptide A9 (UGT1A9))
-
Autre désignation
- UGT1A9
-
Sujet
- UGT1A9 is a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. UGT1A9 is active on phenols.
-
Poids moléculaire
- 57 kDa (MW of target protein)
-
Pathways
- Steroid Hormone Biosynthesis, Regulation of Lipid Metabolism by PPARalpha
Antigène
-